BackMyovant Sciences Overview

Myovant Sciences Cost of Revenue

Cost of Revenue analysis for MYOV.

Quarterly Cost of Revenue

$34.23M
↑ 109.6% YoY

As of Dec 31, 2022

Annual Cost of Revenue (TTM)

$102.26M
↑ 185.85% YoY

Trailing 12 months ending Dec 31, 2022

Average Cost of Revenue (Comparison Companies)

Cost of Revenue History

Cost of Revenue Comparison

Annual Cost of Revenue Growth Rate (%)

Annual Cost of Revenue Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin